首页|期刊导航|中国食品药品监管|2025年甘肃省药品、医疗器械、化妆品投诉举报信息分析与对策思考

2025年甘肃省药品、医疗器械、化妆品投诉举报信息分析与对策思考OA

Analysis of Complaints and Reports on Drugs,Medical Devices,and Cosmetics in Gansu Province in 2025 and Countermeasures

中文摘要英文摘要

投诉举报是发现产品风险、维护公众健康权益的重要社会治理渠道.当前工作中存在的信息沟通不畅、结果反馈不及时、处理程序不规范等问题,在一定程度上影响了公众的参与度和对监管效能的信任度.为改进和提高投诉举报工作的处理效率、规范性与公信力,建立更加高效、便捷、公正的工作机制,本文基于对2025年甘肃省药品、医疗器械、化妆品投诉举报数据的分析,梳理了信息反映的主要风险信号,探讨了工作中存在的问题与面临的挑战,进而提出相关思考:构建部门协同、上下联动的工作机制,加强社会共治、智慧监管,夯实基层机构能力建设,压实各级投诉举报受理机构的主体责任.

Complaints and reporting constitute a crucial channel of social governance for identifying product risks and safeguarding public health rights.However,current practices face several challenges,including inefficient information communication,delayed feedback on handling outcomes,and non-standardized procedures,which have undermined public participation and trust in regulatory effectiveness to some extent.To improve the efficiency,standardization,and credibility of complaint handling,and to establish a more efficient,convenient,and equitable mechanism,this article analyzes complaints and reports related to drugs,cosmetics,and medical devices in Gansu Province in 2025.Key risk signals reflected in the data are identified,and existing problems and challenges are examined.Based on these findings,several countermeasures are proposed,including:establishing coordinated and vertically integrated interdepartmental mechanisms;promoting social co-governance and intelligent regulation;strengthening capacity building at the grassroots level;and reinforcing the primary responsibilities of complaint-handling agencies at all levels.

孟学科;牛清煜

甘肃省药品监督管理局审核查验中心甘肃省药品安全调查中心

医药卫生

投诉举报风险分析社会治理智慧监管药品监管

complaints and reportsrisk analysissocial governanceintelligent regulationdrug regulation

《中国食品药品监管》 2026 (3)

118-127,10

甘肃省药品科研项目(2024GSMPA069)

10.3969/j.issn.1673-5390.2026.03.012

评论